Dongwha Pharm.Co.,Ltd (KOSE:A000020) agreed to acquire a 53.3% stake in MEDYSSEY Co.,Ltd (XKON:A200580) from Jongwook Jang, Min-kyung Jang, Ho-jeong Kim, Ji-won Jang and Seon-ok Kim for KRW 19.6 billion on July 24, 2020. As part of the transaction, Dongwha Pharm.Co.,Ltd will acquire 1,598,358 shares from Jongwook Jang, 62,000 shares from Seon-ok Kim, 16,420 shares from Min-kyung Jang, 16,420 shares from Ji-won Jang and 325,000 shares from Ho-jeong Kim in MEDYSSEY Co.,Ltd. Board of Directors of MEDYSSEY Co.,Ltd resolved the transaction and it is expected to close on September 24, 2020.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10,940 KRW | 0.00% | 0.00% | +4.79% |
1st Jan change | Capi. | |
---|---|---|
+4.79% | 27.66M | |
+13.16% | 129B | |
-9.36% | 10.77B | |
+3.60% | 9.05B | |
+19.75% | 7.38B | |
+22.28% | 4.88B | |
+7.55% | 3.41B | |
-0.21% | 3.07B | |
-4.80% | 2.24B | |
-4.72% | 2.12B |
- Stock Market
- Equities
- A200580 Stock
- News MEDYSSEY Co.,Ltd
- Dongwha Pharm.Co.,Ltd agreed to acquire 53.3% stake in MEDYSSEY Co.,Ltd from Jongwook Jang, Min-kyung Jang, Ho-jeong Kim, Ji-won Jang and Seon-ok Kim for KRW 19.6 billion.